Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2024-514528-17-00Phase 4Completed
Phase 4, randomised, double-blind trial in Vitamin D deficiency (VDD) comparing Deltius arm with Calcifediol arm (2 arms). Primary endpoint: Achievement of 25-hydroxyvitamin D at least 20 ng/mL at 6 weeks. Started Aug 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2024-514528-17-00.